| http://www.w3.org/ns/prov#value | - The main conclusion (about the benefits of triple therapy for genotype 1 viral infections) appears reliable but is based on relatively few trials.Implications of the review for practice and researchPractice: The authors stated that triple therapy was a valid alternative to dual therapy; the choice of protease inhibitor should be guided by factors such as cost and concern over specific adverse even
|
